2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study.
Edwards JK, Cole SR, Breger TL, Rudolph JE, Filiatreau LM, Buchacz K, Humes E, Rebeiro PF, D'Souza G, Gill MJ, Silverberg MJ, Mathews WC, Horberg MA, Thorne J, Hall HI, Justice A, Marconi VC, Lima VD, Bosch RJ, Sterling TR, Althoff KN, Moore RD, Saag M, Eron JJ. Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study. Annals Of Internal Medicine 2021, 174: 1197-1206. PMID: 34224262, PMCID: PMC8453103, DOI: 10.7326/m21-0065.Peer-Reviewed Original ResearchConceptsGeneral U.S. populationHIV careU.S. populationNorth American AIDS Cohort CollaborationHIV clinical careObservational cohort studyTreatment of adultsRace/ethnicityCohort CollaborationCause mortalityCohort studyHIV infectionModifiable factorsComparable personsObservational studyClinical careHigh riskGeneral populationSociodemographic factorsHealth StatisticsMortalityHIVKaplan-Meier estimatorCareFive years
2019
Racial Differences in Change in Physical Functioning in Older Male Veterans with HIV
McKellar MS, Kuchibhatla MN, Oursler KAK, Crystal S, Akgün K, Crothers K, Gibert CL, Nieves-Lugo K, Womack J, Tate J, Fillenbaum GG. Racial Differences in Change in Physical Functioning in Older Male Veterans with HIV. AIDS Research And Human Retroviruses 2019, 35: 1034-1043. PMID: 30963773, PMCID: PMC6862951, DOI: 10.1089/aid.2018.0296.Peer-Reviewed Original ResearchConceptsPCS scoresPhysical functioningWhite HIVHIV statusMale veteransHealth behaviorsSF-12 physical component summary scorePhysical component summary scoreLower body mass indexHealth conditionsBetter PCS scoresPoorer PCS scoreHIV-negative menLower PCS scoresComponent summary scoresBody mass indexViral load countOlder male veteransChronic health conditionsLack of exerciseBetter health behaviorsWhite male veteransAssociation of demographicGeneral U.S. populationLow socioeconomic statusGender disparities in head and neck cancer chemotherapy clinical trials participation and treatment
Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncology 2019, 94: 32-40. PMID: 31178210, DOI: 10.1016/j.oraloncology.2019.05.009.Peer-Reviewed Original ResearchConceptsChemotherapy clinical trialsNational Cancer DatabaseClinical trialsDefinitive radiotherapyChemotherapy administrationNational Comprehensive Cancer Network guidelinesMultivariable logistic regression analysisNeck squamous cell carcinomaEnd Results ProgramSquamous cell carcinomaClinical trial participationLogistic regression analysisGeneral U.S. populationChemotherapy useDefinitive chemoradiotherapyNCCN guidelinesAdult patientsDefinitive treatmentMultivariable analysisNetwork guidelinesResults ProgramCell carcinomaTrial participationCancer DatabaseU.S. patients
2018
A review of research on smoking among United States Veterans with posttraumatic stress disorder (2006–2016)
Lee C, Shpigel D, Segal K, Esan H, Estey D, Hunt M, Hoff R, Weinberger A. A review of research on smoking among United States Veterans with posttraumatic stress disorder (2006–2016). Military Psychology 2018, 30: 10-26. DOI: 10.1080/08995605.2017.1419020.Peer-Reviewed Original ResearchPosttraumatic stress disorderU.S. veteransSmoking behaviorStress disorderPTSD symptomsLate-onset smokingRates of smokingHigh smoking prevalenceCommon psychiatric disordersSmoking-related behaviorsUnited States veteransGeneral U.S. populationHeavy smokingSmoking prevalenceFavorable outcomePTSD clinicInclusion criteriaStates veteransTreatment needsNicotine dependencePsychiatric disordersSmokingCombat exposurePsycINFO searchesU.S. populationImpact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity
Valentine GW, Hefner K, Jatlow PI, Rosenheck RA, Gueorguieva R, Sofuoglu M. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity. Journal Of Dual Diagnosis 2018, 14: 2-13. PMID: 29083287, PMCID: PMC7131866, DOI: 10.1080/15504263.2017.1384877.Peer-Reviewed Original ResearchConceptsE-cigarette usePsychiatric comorbidityCombustible cigarette useE-cigarettesVeteran smokersQuit ratesNicotine dependenceCigarette useVeterans Affairs Health Care SystemAlveolar carbon monoxide levelsOpen-label studySerious adverse eventsSmoking-related deathsFrequent e-cigarette useMain outcome measuresNumber of cigarettesOne-month followEvidence-based treatmentsTobacco-related harmSubstance use disordersGeneral U.S. populationLower quit ratesNicotine delivery systemsCombustible tobacco useHealth care system
2013
Long‐term safety of ustekinumab in patients with moderate‐to‐severe psoriasis: final results from 5 years of follow‐up
Papp K, Griffiths C, Gordon K, Lebwohl M, Szapary P, Wasfi Y, Chan D, Hsu M, Ho V, Ghislain P, Strober B, Reich K, 1 P. Long‐term safety of ustekinumab in patients with moderate‐to‐severe psoriasis: final results from 5 years of follow‐up. British Journal Of Dermatology 2013, 168: 844-854. PMID: 23301632, DOI: 10.1111/bjd.12214.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, Monoclonal, HumanizedCardiovascular DiseasesClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicDermatologic AgentsDose-Response Relationship, DrugFemaleFollow-Up StudiesHumansInfectionsMaleMiddle AgedNeoplasmsPsoriasisRandomized Controlled Trials as TopicUstekinumabConceptsAdverse eventsSevere psoriasisGeneral U.S. populationSerious AEsOverall mortalityRate of AEsOverall adverse eventsSerious adverse eventsAEs of interestU.S. populationLong-term safetyLong-term safety evaluationPatient management decisionsUstekinumab doseUstekinumab exposureDose groupMore dosesPsoriasis trialsSerious infectionsSafety dataCumulative toxicityCumulative exposurePsoriasisPatientsEvent rates
2005
18 Management of HIVIAIDS in Correctional Settings
Altice F, Springer S. 18 Management of HIVIAIDS in Correctional Settings. 2005, 449-487. DOI: 10.1016/b978-012465271-2/50021-2.Peer-Reviewed Original ResearchClean injection equipmentHepatitis virus BHepatitis virus CPrevalence of HIVSelf-administered therapyArea of HIVSyringe exchange programsGeneral U.S. populationCorrectional settingsObserved therapyHIV infectionHIV medicationsComorbid conditionsMethadone maintenanceOwn medicationsSyringe exchangeNew casesVirus CCommunity settingsMedicationsHIVInformed consentExtensive involvementVirus BU.S. population
2000
Mortality among Homeless and Nonhomeless Mentally Ill Veterans
KASPROW W, ROSENHECK R. Mortality among Homeless and Nonhomeless Mentally Ill Veterans. The Journal Of Nervous And Mental Disease 2000, 188: 141-147. PMID: 10749278, DOI: 10.1097/00005053-200003000-00003.Peer-Reviewed Original ResearchConceptsMortality riskGeneral U.S. populationMental health programsIll veteransCohort membersMortality rateHealth programsRetrospective cohort designU.S. populationHealth care systemPrior hospitalizationAge 45Cohort designOlder veteransElevated riskGeneral populationMale veteransNonsignificant trendAge 55Medical problemsVeterans AffairsCare systemBaselineMortalityAlcohol problems
1989
Initial Assessment Data From a 43-Site Program for Homeless Chronic Mentally Ill Veterans
Rosenheck R, Leda C, Gallup P, Astrachan B, Milstein R, Leaf P, Thompson D, Errera P. Initial Assessment Data From a 43-Site Program for Homeless Chronic Mentally Ill Veterans. Psychiatric Services 1989, 40: 937-942. PMID: 2793097, DOI: 10.1176/ps.40.9.937.Peer-Reviewed Original ResearchConceptsSevere psychiatric symptomsHomeless veteransGeneral U.S. populationResidential rehabilitation servicesInitial assessment dataSubstance abuse problemsMedian ageIll veteransPsychiatric symptomsRehabilitation servicesClinical servicesVeterans AdministrationHealth careU.S. populationAbuse problemsVeteransVeteran ProgramTwo-thirdsAssessment dataThree-fifthsVietnam eraChronicChronicallySymptomsAdministration
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply